SEC Filing Analysis: INTUITIVE SURGICAL INC (ISRG)

Executive Summary

• Trading Significance: Low
• Key Takeaway: An executive conducted a minor, pre-planned sale of stock, representing a negligible fraction of the company's market capitalization. This amended filing corrects a previous report.
• Market Impact: Neutral. The transaction is too small to have any market impact and was executed under a Rule 10b5-1 plan, indicating it was not based on new information.

Company Information

Field	Value
Company	INTUITIVE SURGICAL INC
Ticker Symbol	ISRG
CIK	0001035267
Industry	Orthopedic, Prosthetic & Surgical Appliances & Supplies

Insider Information

Field	Value
Name	Brosius Mark
CIK	0002010300
Title/Position	SVP & Chief Mfg and Supply Chain Officer
Relationship	Officer

Transaction Details

Field	Value
Form Type	4/A
Transaction Date	2025-12-12
Transaction Code	S (Sale)
Security Type	Common Stock
Shares Involved	312
Price Per Share	$547.36
Total Value	$170,776.32
Shares Owned After	595
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$170,776.32
% of Market Cap	0.000088%
Shares Transacted	312
% of Shares Outstanding	0.000087%
Post-Transaction Ownership	595 shares (0.00017% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The ~$171k transaction is trivial for a mega-cap company with a market capitalization of $194.8 billion.
• Ownership Concentration: The insider's post-transaction holding of 595 shares represents an insignificant portion of the total shares outstanding.
• Transaction Significance: The sale represents approximately 34.4% of the insider's direct holdings (312 shares sold out of 907 previously owned). While this is a notable percentage of the insider's personal stake, the absolute value and its size relative to the company's total float are extremely small, rendering the transaction insignificant to the market.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The sale is de minimis relative to the company's market cap and was conducted under a pre-arranged 10b5-1 trading plan. Such transactions are not typically interpreted as signals of an insider's current outlook on the company.

Volume & Sentiment

• Expected Volume Impact: Negligible. The transaction size is too small to affect trading volume.
• Sentiment Indicator: Neutral. Pre-planned sales for diversification or personal financial management do not carry bullish or bearish sentiment.

Additional Context

Transaction Notes

• Special Circumstances: This Form 4/A was filed to amend and correct a previous Form 4 from 2025-12-15. The sale was executed under a Rule 10b5-1 trading plan, which allows insiders to set up a predetermined plan to sell stocks at a future date.